mRNA Momentum: What a Breakthrough Trial Means for Cancer Care and Beyond A recent clinical trial announced on August 19 has sent shockwaves through the biotech industry, with Moderna Inc. and Merck & Co.
reporting a successful Phase 3 trial for their mRNA cancer treatment.
This development marks a significant milestone in personalized medicine, where tailored treatments are designed to target specific genetic mutations within an individual's tumor.